Introduction: Few studies have examined neuropathological changes such as the degenerative necrosis and demyelination of spinal nerve cells accompanying intrathecal administration of opioids (ITO) to relieve refractory cancer pain. Previous studies have produced conflicting results as to whether or not ITO causes nerve tissue damage. The current study neuropathologically investigated autopsy specimens from patients who received ITO. Methods: Subjects were 7 patients who received continuous intrathecal analgesia and who were later autopsied (4 males, 3 females). Six patients were administered morphine and bupivacaine while 1 patient was administered fentanyl and bupivacaine. The duration of administration ranged from 6-345 days. Results: Two patients who received long-term administration of morphine were found to have severe necrotic degeneration and gliosis of spinal neurons and demyelination in the dorsal horn and dorsal roots. However, neuropathological changes were not noted in Patient 4, who was briefly administered morphine, or in the patient who was administered fentanyl. Conclusion: The total dose of morphine used for ITO and the duration of its administration were suggested to be related to the extent of nerve tissue damage. Thus, nerve tissue damage due to ITO might be primarily associated with morphine. Palliat Care Res 2013; 8(2): 192-8
Introduction
Since opioids were first administered to humans in the subarachnoid space in 1979 1) , many patients with refractory cancer pain have received intrathecal administration of opioids. Various neuropathological studies on this method of pain relief have been performed, but most have focused on inflammatory mass formation at the catheter tip, and reports on spinal disorders and nerve damage such as degenerative necrosis and demyelination of spinal nerve cells using human autopsy material are extremely rare [2] [3] [4] .
In 1992, Sjöberg et al. 2) neuropathologically studied 15 patients who received long−term administration of morphine and bupivacaine, a local anesthetic; they reported finding damage to the spinal cord and nerve roots. In 1994, Karlsson et al. 3) similarly reported damage to the spinal nerves. However, in 1997 Wagemans et al. 4) autopsied 10 patients with cancer who had received long−term administration of morphine and bupivacaine, but they reported that there was no nerve tissue damage. Thus, there are contradictory reports as to whether or not this analgesia causes nerve tissue damage.
The current study neuropathologically examined autopsy specimens from patients who received continuous intrathecal administration of opioids.
Methods
Subjects were 7 patients who received continuous intrathecal administration of opioids at Kurume University Hospital from July 2001 to March 31, 2010; these patients were later autopsied (4 males, 3 females; age range: 44−65 years; mean age: 52 years).
One patient had difficulty maintaining a standing position during puncture of the subarachnoid space, so preparations for continuous intrathecal administration of opioids were made under spinal anesthesia; local anesthesia was used for all of the other patients. Implanting of access ports was determined based on the patient' s prognosis.
In 4 patients with a prognosis of 1 month or longer, a kit for an epidural port from Deltec was used along with a polyurethane epidural catheter that was placed in the subarachnoid space; the port was placed on the right midclavicular line above the 8th to 9th rib. A grip- In 3 patients with a prognosis of less than 1 month, an epidural catheter from B. Braun made of polyamide resin was placed in the subarachnoid space. A subcutaneous tunnel of about 30 cm was created and the catheter was fixed in place. The site for catheter insertion was disinfected daily with povidone iodine.
The insertion site was L3/4 in 6 patients and L2/3 in 1. The infusion was a mixture of an opioid and bupivacaine and physiological saline at a total volume of 12 mL/day. The infusion was continuously administered with a syringe pump at a rate of 0.5−1.0 mL/hr. Rescue dose for breakthrough pain was 1/24 of the daily dosage amount of opioid. The drugs infused were morphine and bupivacaine (6 patients) or fentanyl and bupivacaine (1 patient). Autopsy was performed two to 10 hrs after death and specimens were collected.
After confirming the site for catheter insertion and the location of the catheter tip, the spinal cord from the thorax (T8) to the lumbar region (L5) was removed along with the dura mater and fixed with 10％ paraformaldehyde. After fixation, the spinal cord was sectioned every 1.5 cm. Specimens 5 mm thick were prepared and embedded in paraffin. Paraffin blocks were sectioned and subjected to hematoxylin eosin staining. Myelin sheath staining was performed to better visualize demyelinated lesions and glial fibrillary acidic protein (GFAP)
immunostaining was performed to confirm gliosis.
Results
Characteristics of the 7 patients, the types of opioids administered, the site of catheter insertion, and the location of the catheter tip are shown in Table 1A .
Autopsies were performed on all 7 patients; patients consisted of 4 males and 3 females ranging in age from 44−65 years (mean age: 52 years). The primary cancer was rectal cancer in 2 patients, cervical cancer in 2, ureteral cancer in 1, prostate cancer in 1, and undifferen- The total dose of opioid and bupivacaine and duration of their administration are summarized along with neurohistopathological findings in Table 1B . Additionally, the range of dosage amounts of opioid and bupivacaine (mg/day or μg/day) (lowest dose−peak dose) and infusion pump flow rate (infusion rate) (mL/h) are indicated in Table   1C . Severe necrotic degeneration and gliosis of spinal neurons and demyelination in the dorsal horn and dorsal roots were noted in Patients 2 and 3, who received long−term administration of morphine.
These neuropathological changes were most distinct near the tip of the catheter, but weak damage to the spinal cord was recognized over a wide range, including areas distant from the tip of the catheter.
However, these neurohistopathological findings were not noted in patients who only received morphine for a brief period. Although Patient 7 received long−term administration of fentanyl, necrotic degeneration and gliosis of spinal neurons and demyelination in the dorsal horn and dorsal roots were not noted.
Discussion
Several factors could possibly lead to nerve damage during intrathecal administration of opioids. These include the catheter itself, the type of drugs (morphine, bupivacaine, etc.) administered, direct effects of cancer invasion, therapeutic anticancer drugs, and radiation therapy. With regard to the catheter, those used in the current study were made of polyurethane or a polyamide resin. In experiments with dogs, polyurethane catheters were reported to cause inflammatory masses in the subdural space 5) . On the other hand, in research in which
Yaksh et al. 6) used a dog and administered 1. future study with additional cases is needed. Mercadante et al. 7) reported that there were no neurological sequelae and that neurotoxicity did not readily develop if the dose of bupivacaine did not exceed 30−60 mg/day. Additionally, Perren et al. 8) have reported that inflammatory mass forming in the spinal cord has been recognized in cases in which intrathecal administration of a mixture of bupivacaine and clonidine has been continued for three years or more. In these cases, the dosage of bupivacaine was 24−26.6 mg/day. The dose of bupiva- caine given to the current patients was about 5−60 mg/day, which was almost the same as daily dosage that reported by Mercadante et al. 7) Compared to the daily dosage administered by Perren et al. 8) (24−26.6 mg/day), while our daily dosage (5−60 mg/day) was higher, the period of administration was shorter, at less than one year for all our cases.
Long−term administration of bupivacaine might cause neurotoxicity even in the dosage commonly used. Table 2 compares our autopsied patients with those in previous studies. There were no major differences in the doses of morphine and bupivacaine and duration of their administration. As in the current study, Sjöberg et al. 2) found nerve damage, however a study by Wagemans et al. found no nerve damage 4) . Further study is needed to clarify this discrepancy.
Another factor to examiner is cancer metastasis. Cancer was found outside the dura mater in Patient 2. Metastases were large enough to be identified microscopically but nerve damage was not noted in their vicinity, so the cancer was not associated with nerve damage. Localized fibrosis and inflammation of the subdural space were not noted in Patients 2 and 3, who had severe nerve damage, so the inflammatory masses observed in our study were unlikely to have resulted from morphine and bupivacaine. Thus, we consider that the nerve damage in our patients was caused by long−term administration of morphine to the subarachnoid space. In humans, continuous infusion of morphine intrathecally is clinically reported to cause dysfunction and paralysis of sensory nerves and motor nerves 11, 12) . A conflicting report, however, indicated that high doses of morphine administered intrathecally over a long period of time (i.e. 90 days) did not produce clinical neurologic deficits 13) . A study of autopsy specimens from patients who were administered morphine intrathecally for a long period of time also noted no nerve damage 14) . Thus there are contradicting reports, and no consensus has been reached on this issue. In our experiment, spinal cord nerve damage resulting from the long−term administration of morphine to the subarachnoid space was histopathologically observed, but neurological deficit such as sensory 
Conclusion
The total dose of morphine used for intrathecal analgesia and the duration of its administration were related to the extent of nerve damage. Animal experiments and human studies have both indicated that nerve damage due to intrathecal analgesia is primarily associated with morphine. In line with other reports, bupivacaine did not lead to nerve damage at the doses administered to patients in the current study. In addition, the current results suggested that long−term administration of fentanyl may not cause nerve damage.
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